Phase 3 Study of Nemvaleukin Alfa in Combination With Pembrolizumab in Patients With Platinum-Resistant Epithelial Ovarian Cancer (ARTISTRY-7)

Clinical trial NCT05092360 · TERMINATED

Trial details

NCT number: NCT05092360
Sponsor: Mural Oncology, Inc
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Platinum-resistant Ovarian Cancer Fallopian Tube Cancer Primary Peritoneal Cancer

Start date: 2022-01-10
Primary completion: 2025-01-08
Enrollment: 456

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.